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Not only bacteria but also fungal pathogens, particularly Candida species, can lead to biofilm
infections on biomedical devices. By covalent grafting of the antifungal drug caspofungin, which
targets the fungal cell wall, onto solid biomaterials, a surface layer can be created that might be
able to provide long-term protection against fungal biofilm formation. Plasma polymerization of
propionaldehyde (propanal) was used to deposit a thin (20 nm) interfacial bonding layer bearing
aldehyde surface groups that can react with amine groups of caspofungin to form covalent inter-
facial bonds for immobilization. Surface analyses by x-ray photoelectron spectroscopy and time-
of-flight secondary ion mass spectrometry confirmed the intended grafting and uniformity of the
coatings, and durability upon extended washing. Testing for fungal cell attachment and ensuing
biofilm formation showed that caspofungin retained activity when covalently bound onto surfa-
ces, disrupting colonizing Candida cells. Mammalian cytotoxicity studies using human primary
fibroblasts indicated that the caspofungin-grafted surfaces were selective in eliminating fungal
cells while allowing attachment and spreading of mammalian cells. These in vitro data suggest
promise for use as antifungal coatings, for example, on catheters, and the use of a plasma polymer
interlayer enables facile transfer of the coating method onto a wide variety of biomaterials and
biomedical devices. VC 2015 American Vacuum Society. [http://dx.doi.org/10.1116/1.4933108]
I. INTRODUCTION
The clinical problems arising from bacterial colonization
of biomedical devices and ensuing infections have long been
well documented and have given rise to a considerable body
of research on antibacterial coatings.1 More recently, it has
also become evident that fungal pathogens can also form in-
fectious biofilms, either by themselves or in coexistence
with bacteria.2–5 Fungal infections can be life-threatening
for immunocompromized patients and, in some cases, may
have higher mortality rates than bacterial infections.6
Invasive biomedical devices such as catheters, lines, drips,
and implants are a major risk factor for fungal infections, as
they are associated with nonsterile sites providing environ-
ments for colonization by opportunistic and pathogenic bac-
teria and fungi to form biofilms.7 The most common hospital
acquired infections are urinary tract infections, ventilator
associated pneumonia, and bloodstream infections,8 all of
which can lead to septic shock and death, as well as to the
formation of biofilms on medical devices; once formed, bio-
films are much more difficult to eradicate. The impact of
fungal Candida species in infections has been under-
appreciated although they cause over 400 000 life-
threatening infections globally per year and are the third
most common cause of catheter-associated bloodstream
infections, with a mortality reaching 45%.9,10
The most frequently encountered pathogen in this genus,
Candida albicans, is a fungal organism that normally colo-
nizes mucosal tissues, forming part of the microflora in an
opportunistic manner. Its population is normally controlled
by the mucosal microenvironment, the bacterial flora, and
through a healthy innate immune system.11 It can colonize
humans from birth and persist as a lifelong commensal in the
gastrointestinal tract. It is dimorphic in that it can undergo a
reversible transition between yeast and hyphae growth
forms; invasive infection usually occurs in the hyphal form.
When fungal cells infect the blood stream (referred to as
candidemia), and when hyphae spread to internal organs, it
can become a deep-seated, invasive infection with high mor-
tality rates.
Evidently, C. albicans can also spread to and colonize the
surfaces of biomedical devices to form sessile biofilms.
Their treatment can be challenging and seriously affects
patients already weakened by disease or trauma. Thus, there
is a need for surface treatments or thin coatings that can be
applied onto existing medical devices so as to make the sur-
face unsuitable for attachment and biofilm formation by
Candida species. Such antifungal surfaces must also meet
criteria such as compatibility with human cells and tissue;
antiseptic coatings can stop microbial attachment, but they
are cytotoxic.12 Given the biological similarities in fungal
and human cells (both eukaryotic), selective antifungal strat-
egies are required. Approaches fall into two classes: release
or covalent surface grafting of antifungal compounds.13
Release approaches are inherently of limited duration of
effectiveness, and as drug molecules diffuse away or move
with secretions, they may not reach the minimum inhibitory
concentration.14 Accordingly, we prefer the approach of
equipping biomaterials with a covalently grafted layer of
antifungal molecules, which might provide long-lastinga)Electronic mail: bryan.coad@unisa.edu.au
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protection against colonization and prevents accumulation of
released drug molecules in organs. However, this approach
would seem unsuitable for drugs that have intracellular tar-
gets, even with the use of spacer linkers, and we thus focus
on the grafting of drugs that have known targets in the cell
envelope. Even then, a drug might become inactive when
grafted covalently onto solid biomaterials surfaces due to
steric hindrance or conformational effects. In addition, one
must be careful to consider and eliminate effects arising
from physisorbed molecules diffusing into the medium and
killing fungal cells in solution during testing, before con-
cluding that a grafted layer indeed exhibits activity.
For this study, we have selected the antifungal compound
caspofungin (Fig. 1), a member of the echinocandin class of
lipopeptides. Its fatty acid side chain is thought to intercalate
with the phospholipid bilayer of the cell membrane, and cas-
pofungin then acts by noncompetitive inhibition of the syn-
thetic cell wall enzyme complex b-1,3-D-glucan synthase.
This prevents the synthesis of b-1,3 glucan, an essential com-
ponent of the fungal cell wall, and causes osmotic lysis of the
fungal cells. Effects are both fungistatic and fungicidal.15,16
Most biomaterials and medical devices, however, do not
possess chemical groups on their surfaces capable of cova-
lent interfacial immobilization of caspofungin. Accordingly,
we first apply a thin interfacial bonding layer, being a plasma
polymer deposited from the process vapor propionaldehyde
(propanal); this polymeric interlayer has been found to be
useful for immobilizing a variety of bioactive molecules
bearing primary amine groups.17,18 Distinct advantages of
this approach also comprise that plasma polymers adhere
well to most substrate materials, exhibit excellent uniformity
and process reproducibility, and the coating technology can
readily be transferred to a wide range of potential products.
Here, we report the method of immobilization of caspofun-
gin and data showing effectiveness of this coating against




Caspofungin (Sigma-Aldrich) was covalently immobilized
onto intermediate coatings approximately 18–20 nm thick, as
determined by ellipsometry, prepared by the plasma polymer-
ization (pp) of propionaldehyde (ALD, 99%, Aldrich) using a
plasma deposition system described previously.19 The initial
reaction between primary amine groups of caspofungin and
aldehyde groups of the ALD-pp leads to interfacial imine
bonds, which were reduced to stable amine bonds using
NaBH3CN; this has been documented previously to lead to
stable covalent attachment.18 Substrates used included silicon
wafers (Micro Materials and Research Consumables,
Australia), Thermanox cover slips (ProSciTech, Australia),
and IBIDI 15 l-slide 12-well uncoated microscopy chambers
(Cat. no. 81201, IBIDI, Australia). All work was undertaken
in a clean biohazard cupboard, except plasma polymerization.
Caspofungin was prepared as a 0.1 mg/ml solution in
phosphate-buffered saline. For grafting, 100 ll of this solution
was added per sample to cover the surface, and 100 ll of
1 mg/ml NaBH3CN added after 1–2 h contact. Samples were
incubated overnight at 18 C. Before fungal testing, samples
were either soaked and rinsed a minimum of 12 times over 2
h each, with Milli-Q water, or soaked for 2 weeks and rinsed
before testing. The final rinse was collected and tested against
fungi to prove that no antifungal compounds were eluting and
prevention of fungal attachment was indeed from a covalently
attached caspofungin surface layer only.
B. Surface analysis
Chemical compositions of coatings and their uniformity
across different positions on the surface were analyzed by
x-ray photoelectron spectroscopy (XPS) and time-of-flight
secondary ion mass spectrometry (ToF-SIMS). XPS was per-
formed with a Kratos AXIS Ultra DLD spectrometer, using
monochromatic AlKa radiation (h¼ 1486.7 eV) and a mag-
netically confined charge compensation system. Spectra
were recorded using an acceleration voltage of 15 keV at a
power of 225 W. Survey spectra were collected with a pass
energy of 160 eV and an analysis area of 300 700 lm.
High-resolution spectra were obtained using a 20 eV pass
energy and an analysis area of 300 700 lm. Data analy-
sis was performed with CASAXPS software (Casa Software,
Ltd.). All binding energies were referenced by charge cor-
rection to the “neutral” C 1s peak at 285.0 eV. Core level
envelopes were curve-fitted with the minimum number of
mixed Gaussian–Lorentzian component profiles. The
Gaussian–Lorentzian mixing ratio (typically 30% Lorentzian
and 70% Gaussian functions); the full width at half maxi-
mum, and the positions and intensities of peaks were left
unconstrained to result in a best fit but outcomes were also
checked by constrained fitting.
ToF-SIMS measurements were performed with a PHI
TRIFT V nanoTOF instrument (PHI Electronics, Ltd.,
USA). A 30 keV, pulsed primary Auþ ion beam was used to
sputter and ionize species from each sample surface. The
instrument’s dual beam charge neutralization system using a
combination of low energy argon ions (up to 10 eV) and
electrons (up to 25 eV) was employed to provide excellent
charge neutralization performance. Positive mass axis
FIG. 1. Chemical structure of caspofungin; MW 1093.31 C52H88N10O15.
Highlighted fragments with m/z ¼ 86 (shown in pink) were useful for con-
firming the surface attachment (see main text for details).
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þ. Spectra were acquired in the bunched mode for 60 s
from an area of 100 100 lm. The corresponding total pri-
mary ion dose was <1 1012 ions cm2, and thus met the
static SIMS regime.20 A mass resolution m/Dm of >7000 at
nominal m/z¼ 27 amu (C2H3þ) was typically achieved.
Some samples were further characterized by collecting
multiple positive ion mass spectra from at least eight distinct
areas that did not overlap on a given sample surface, and
working them up by principal component analysis (PCA).
All recognizable, clear (i.e., unobscured by overlap) frag-
ment ions from 2 to 175 amu were used in PCA calculations.
Peaks were normalized to the total intensity of all selected
peaks and the multiple spectra processed using previously
reported procedures and checks,21 using PLS_TOOLBOX version
3.0 (Eigenvector Research, Inc., Manson, WA) along with
MATLAB software v. 6.5 (MathWorks Inc., Natick, MA).
C. Fungal testing
C. albicans (ATCC 90028) was plated on SABþANTI
(Oxoid) medium from 80 C frozen stock and incubated
overnight at 37 C, then one colony was picked from the
plate and spread on fresh medium and incubated at 35 C
overnight as a stock plate. The other colonies were collected
and frozen for future experiments. One colony was selected
from the stock plate and grown in 10 ml YPD Broth (20 g
glucose, 20 g peptone, 10 g yeast in 500 ml RO water,
Oxoid)22 overnight at 35 C. The following day this was
measured for optical density and made up to 0.5 McFarland
using a Vitek colorimeter, then diluted 1/100 to give approx-
imately 1 106 cfu/ml. Depending on the sample sizes,
Candida solutions were added at 100 or 300 ll (thus provid-
ing fungal numbers of 1 105 or 3 105) and incubated
for 3 days at 35 C, followed by rinsing twice to remove
loosely attached and yeast-form fungi. Surfaces were ana-
lyzed using LIVE/DEAD BacLight Bacterial Viability
assays kits (Invitrogen), which is the same as the fungus
live/dead imaging kit, and also using the FUN1 kit
(Invitrogen).
D. Mammalian cell toxicity studies
Primary human fibroblasts were harvested from fresh skin
and maintained according to published protocols using
Dulbecco’s Modified Eagle’s Medium and 10% fetal bovine
serum.23 Thermanox cover slips without a coating (as a
control) and with coatings were placed in sterile 24-well
culture plates (NUNC, Invitrogen) and prewarmed in a cell
culture oven. Cell solutions were made up to 10 000 cells/ml
in medium/serum and added till 1 ml to each well or 100 ll
to IBIDI wells. Well plates were placed into a culture oven
and left for 48 h. Cover slip samples were rinsed to remove
nonadherent cells and placed on a glass slide and covered
with a cover slip for immediate microscopic analysis. Cells in
IBIDI wells were stained using 40,6-diamidino-2-phenylindole
nucleus stain (Invitrogen) used as per instructions.
III. RESULTS
Prior to biological testing, it was necessary to confirm the
presence and uniform coverage of surface-grafted caspofun-
gin molecules by surface analytical techniques, so that reli-
able interpretation of observed biological responses can be
assured, free from possible artefacts such as adventitious sur-
face contaminants and coating nonuniformity.
A. XPS analysis
XPS is well suited to detect the presence of surface-grafted
caspofungin, since this compound contains amine and amide
groups, whereas the substrates used and the ALD-pp inter-
layer do not contain N. The atomic percentage of N could in
principle also be used to estimate the surface coverage of cas-
pofungin via an overlayer model. Table I shows representative
XPS data with the elemental surface composition for the
ALD-pp control coating and after grafting of caspofungin.
The composition of the ALD-pp surface was similar to previ-
ous work.24 After exposure to caspofungin and reducing agent
and extensive washing, the observed composition of the cas-
pofungin surface showed the presence of N and a higher per-
centage of O compared to the control surface, which accords
with expectations based on the chemical structure of the com-
pound. The relative abundance of N is lower than the theoreti-
cal percentage for pure caspofungin, which indicates that the
grafted layer is thinner than 10 nm. This is entirely reasonable
for a (vacuum-dried) monolayer of a molecule of this size.
The observed %N suggests that the surface coverage is likely
to be close to monolayer, though detailed overlayer calcula-
tions are not warranted given that we cannot ascertain the ori-
entation/conformation of grafted caspofungin.
High-resolution XPS N 1s spectra (not shown) recorded
with the caspofungin-grafted surface show both amine N (at
399.3 eV) and amide N (400.0 eV), in accord with expecta-
tions based on the molecular structure of caspofungin.
XPS analysis was repeated after soaking caspofungin-
grafted samples in water for 2 weeks; elemental composi-
tions (not shown) were identical within experimental uncer-
tainty (estimated at 65% for N at this atomic ratio), thus
confirming that the initial rinsing had removed any physi-
sorbed caspofungin that might have been present initially.
Hence, these data suggest that the extensively rinsed samples
subjected to biological tests contained only covalently
grafted caspofungin with no measurable amounts that could
desorb and affect fungal cells in solution.
TABLE I. Compositional analysis by XPS.
Composition (at. %)
Sample O N C
ALDpp 12.5 0 87.5
ALDpp-caspofungin 13.2 2.6 84.3
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B. ToF-SIMS analysis
While XPS analysis provides quantitative data on elemen-
tal compositions, it has limited chemical information content,
and it is desirable to complement XPS data with a chemically
more informative analysis technique, so as to check the
expected surface chemistry. ToF-SIMS is well suited due to
its ability to reveal molecular fragments and hence confirm
specific molecular structures, though it is not a quantitative
method. Figure 2 shows positive ion ToF-SIMS spectra
recorded on ALD-pp and ALD-pp þ caspofungin samples.
While in the lower mass region the peaks were rather similar,
corresponding to fragment ions that can be ejected both from
the ALD-pp and from caspofungin, there are signals from
higher mass fragment ions that are more informative. The
most pronounced of these was a signal at m/z¼ 86. A high
resolution, narrow-range scan (not shown), coupled with this
instrument’s resolution of Dm/m of 1/11 000, established its
identity as C4H8NO
þ, a fragment ion that can readily be
assigned to originating from at least three parts of the molecu-
lar structure of caspofungin, as shown with pink highlighting
in Fig. 1. Such signals are useful in providing confidence that
the analyte surface is indeed the intended grafted caspofungin
layer, as opposed to possible adventitious contaminants.
ToF-SIMS can be used to probe for uniformity of coating
coverage by recording spectra on multiple independent areas of
a sample and performing PCA.21 This is important in work on
antimicrobial coatings because coating defects could give rise
to localized attachment of microbes followed by nucleation of
biofilm clumps. Eight sets of spectra each were collected from
distinct areas of two samples and subjected to PCA analysis.
The clear separation of the two data clusters along the PC1
axis [Fig. 3(a)] is confirmation of clearly distinct surface chem-
ical compositions, and the tight clustering of the individual
data points within the two sets indicates a high degree of uni-
formity of the surface compositions of both samples.
The loadings plot of positive ions [Fig. 3(b)] was examined
to determine which ion signals provided the most significant
contributions to compositional differences between the two
samples. With a positive score on PC1 for the caspofungin-
grafted sample, the fragment ions that load positively are
those that are relatively more intense in the spectra from the
grafted surface. The most pronounced differences are
observed for ions that contain N, for example, C3H6NO
þ and
C4H8NO
þ, which is consistent with the putative presence of
caspofungin. We also note that several CxHyO
þ ions load neg-
atively, consistent with expectation that their intensity would
be greater from the ALD-pp surface.
Thus, the ToF-SIMS data indicate effective and uniform
grafting of caspofungin onto the ALD-pp surface. The peaks
identified in the loadings plot can all be assigned to fragments
within the molecular structure of caspofungin; there are no
peaks, suggesting the presence of surface contamination.
C. Fungal colonization
Prior to assessing ALD-pp and ALD-pp þ caspofungin
coatings for colonization by C. albicans, the viability of
assessment of colonization of surfaces via live/dead staining
was ascertained using a standard tissue culture polystyrene
FIG. 2. Positive ion ToF-SIMS spectra recorded on (a) control ALD-pp sam-
ple and (b) caspofungin grafted sample.
FIG. 3. PCA Scores plot on PC1 and PC2 (a), and loadings on PC1 (b), of
positive ion mass spectra recorded on ALDpp and ALDpp-caspofungin
(ALDpp-Casp) surfaces.
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(TCPS) surface. After 48 h, visual assessment showed partial
surface coverage by a fungal biofilm. For metabolically
active yeast cells, the dye kit stains cells green, as shown in
Fig. 4(a). On the other hand, cells that are dead or in the pro-
cess of dying are indicated by an intermediate orange color.
This was shown when the cells were exposed to Virkon for
10 min [Fig. 4(b)]. Virkon is composed of oxone, sodium
dodecylbenzenesulfonate, and sulfamic acid and is a broad
spectrum antiseptic solution.
On the aldehyde plasma polymer surface also, C. albicans
managed to attach and form colonies, though the rate of for-
mation of biofilm was reduced compared with the TCPS sur-
face (Fig. 5).
In contrast, over the same time period of 48 h,
caspofungin-grafted samples displayed excellent prevention
of biofilm formation (Fig. 6). While some fungal cells man-
aged to attach (to an extent resistant to removal by gentle rins-
ing), they then were killed, as evident by the staining, and the
killing must have been sufficiently fast to prevent any initia-
tion of biofilm formation. Higher resolution also shows shapes
indicative of cells with damaged membranes, and there were
no intact yeast cells or hyphae found on caspofungin-grafted
surfaces. It should be noted that there is some green color
[Fig. 6(a)], but not in the shape of live cells; rather, there is
some absorption of the green dye into the ALD-pp coating.
This diffuse background color is easily distinguished by visual
observation but unfortunately interferes with measurement of
optical absorbance; accordingly, we prefer to present these
images rather than absorbance data with problematic back-
ground correction. For improved visualization of dead fungal
cells against the diffuse green background, a filter eliminating
the green fluorescence can be utilized [Fig. 6(b)]. Figure 6(c)
shows an enlarged image of dead fungal cells that are mis-
shapen and appear to be leaking. In the 100 image [Fig.
6(d)], again only dead fungi were observed, with apparent
leaking and broken hyphae. This appearance is consistent
with substantial damage to the cell wall and membrane, as
one would expect when caspofungin inhibits the synthesis of
a crucial cell wall component.
While XPS data indicated that caspofungin was stably
attached onto the ALD-pp interlayer, biological testing was
also performed after extended (2 weeks) soaking in Milli-Q
water. As for fresh (but well-rinsed) samples, there was a clear
difference in performance between the ALD-pp and the ALD-
ppþ caspofungin samples (Fig. 7). As for fresh (but well-
rinsed) samples, there was a clear difference in performance
between the ALD-pp and the ALD-ppþ caspofungin samples
(Fig. 7), but for both types of surfaces the performance did
not change upon such extended washing. Caspofungin has a
high solubility in water and hence any physisorbed molecules
should be removed after 2 weeks of soaking. Thus, we con-
clude that caspofungin was covalently grafted and thus able to
maintain activity after extended contact with water, amount-
ing to a long-lasting antifungal coating. While the aldehyde
control surface showed multiple yeast cells and some pseudo-
hyphae [Fig. 7(a)], the caspofungin surface treatment showed
only a few attached cells [Fig. 7(b)], which may be a conse-
quence of some small coating defects due to the unavoidable
presence of some dust particles during coating. Those few
cells, however, seemed unable to spread and form colonies,
presumably due to the inhospitable caspofungin surface
around them. Combined with the observation of no antifungal
activity of the soaking solution, we can exclude a possible
contribution by leaching caspofungin. Thus the data indicate
that the ALD-ppþ caspofungin coating acts by a surface-con-
tact-killing mechanism and not one that requires release of the
compound. These experiments demonstrate a good qualitative
overview of the fungal cell killing and prevention of biofilm
formation on surfaces and provide a basis for future investiga-
tions. Subsequent studies will quantify the antifungal surface
effect by comparing the number of colony-forming units that
remain viable or are killed after exposure to control and
caspofungin-treated surfaces, respectively. Such quantitative
studies will be important for statistically evaluating the data.
D. Cytotoxicity assessment
Aldehyde plasma polymer “control” surfaces and
caspofungin-grafted surfaces were examined for possible
toxicity to primary human fibroblasts, harvested from human
FIG. 4. Live/dead staining of C. albicans colonies grown for 48 h on TCPS:
(a) positive control with mostly live fungal cells (stained green), and (b)
after treatment with Virkon antiseptic for 10 min (dead/dying cells stained
yellow–orange; some live cells are also visible). Rounded yeast cells are
evident with also some elongated hyphal structures.
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skin. Figures 8(a) and 8(b) show microscopy images of cul-
tured cells on these two surfaces.
On both types of samples, fibroblast cells were able to
attach and grow to similar extent, and there were no
observable differences in cell morphology examined up to 3
days of growth. Figure 9 shows cell counting data showing
no significant difference in the number of cells observed in
the microscopy images.
FIG. 5. C. albicans biofilm formation on ALD-pp after 48 h: (a) entire sample inside well (24-well plate), (b) 60 image, (c) 100 image, and (d) on TCPS
surface, entire sample imaged, showing more extensive but patchy biofilm formation.
FIG. 6. C. albicans on caspofungin-grafted surfaces after 48 h incubation: (a) full view of sample; (b) same with filtering of green background, (c) 60 image
showing dead yeast cells, and (d) 100 image showing changes in yeast and hyphal morphology.
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IV. DISCUSSION
Surface analysis data indicate that covalent grafting of
caspofungin onto the aldehyde plasma polymer interlayer
leads to a good grafting yield and uniform surface coverage,
and the biological tests show selective changes in activity
upon grafting of this antifungal compound. The aldehyde
plasma polymer by itself supports the attachment and growth
of C. albicans and primary human fibroblasts, to an extent
similar to such colonization observed on a range of other
polymeric surfaces. Low molecular weight aldehyde com-
pounds leaching from the aldehyde plasma polymer could be
toxic to both fungal and mammalian cells, but do not seem
to be present in any significant quantities. Besides, samples
are routinely rinsed. Upon covalent immobilization of caspo-
fungin, however, the biological performance changes mark-
edly; while the colonization of the coating by fibroblasts is
unchanged, biofilm formation by C. albicans is inhibited
completely. Microscopy images show that some C. albicans
cells manage to attach but are then killed before they can ini-
tiate biofilm formation. Testing after extended soaking in
water suggests that the observed effects are not attributable
to physisorbed, leaching drug molecules. Hence, we con-
clude that our data support the hypothesis that irreversibly
surface-immobilized caspofungin retains antifungal activity.
Based on traditional solution studies, the putative antifun-
gal mechanism of caspofungin is to disrupt b-1,3-D-glucan
synthase, an important enzyme in the production of the pro-
tective cell wall. The C. albicans strain chosen for this work
was determined to be susceptible to caspofungin with a
solution minimum inhibitory concentration (MIC) in the range
of 0.125 mg/l in accordance with the observation of others.25
When attaching onto solid surfaces, C. albicans undergoes
FIG. 7. C. albicans on (a) aldehyde plasma polymer surface, and (b)
caspofungin-grafted surface, both soaked for 2 weeks prior to testing.
FIG. 8. Attachment and growth for 3 d of primary fibroblasts on (a) ALD-pp
surface, and (b) on caspofungin-grafted surface.
FIG. 9. Primary human fibroblast cells per view area; three independent rep-
licates each. Control surfaces were coated with aldehyde plasma polymer.
Caspofungin surfaces were prepared by binding 1.0 mg/ml caspofungin onto
aldehyde plasma polymer surfaces as described in the methods.
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morphology changes including budding, and transitioning to
hyphae. Therefore, it is difficult to compare MIC values to
an expected surface density of immobilized caspofungin
molecules because of the different ways that yeasts would be
exposed to either freely circulating or immobilized caspo-
fungin. Additionally, hyphal development is associated with
the virulence of this organism and would also seem impor-
tant in the first stages of biofilm formation on surfaces. One
possible mechanism by which surface-attached caspofungin
could cause a fungicidal effect is that the antifungal agent is
able to disrupt the integrity of the cell wall during these mor-
phological changes. When attempting to either replicate or
spread on the surface through hyphal formation, the
increased reliance on cell wall remodeling and therefore, the
production, reorganization and dismemberment of glucans in
the cell wall requires upregulation of these enzymatic path-
ways. Therefore, we would expect an increased reliance on
b-1,3-D-glucan synthase in the construction of new cell wall
elements particularly at the cell/biomaterial interface—a
process which is met by inhibition by the surface-attached
drug.
It should be noted that there has been discussion of other
mechanisms by which caspofungin may act, including alter-
ing the cell morphology,26–28 lowering the cell wall mechan-
ical strength, and increasing the sensitivity to osmotic
pressure, which could eventually lead to cell lysis and
death.29,30 Studying the relevance of these postulated mecha-
nisms in the context of surface-bound echinocandins would
need to be established through further experimentation.
However, the cytotoxicity data shown above indicate that
only fungal cells and not human fibroblasts (which do not
contain glucan-based cell walls) are susceptible to caspofun-
gin. This lends support to the hypothesis that the inhibition
of b-1,3-D-glucan synthase by the contacting caspofungin
surface coating is important in the selective elimination of
fungal cell colonization. Further investigation will be needed
to establish mechanistic details of fungal responses upon
contact with solid surfaces both with and without attached
drug molecules and in the presence of protein. A useful
methodology would seem to be the use of continuous mi-
croscopy live cell imaging, which may pick up the kinetics
of dimorphic changes that may be affected by the presence
of coatings. Additionally, studies investigating phenotypic
changes could be undertaken to advance the understanding
of the relevance of morphological changes.
Even in the absence of detailed molecular mechanistic
understanding, however, it is clear that covalently grafted
caspofungin coatings offer promise for combatting fungal
infections on biomedical devices, given that C. albicans
plays a prominent role in device-related infections in human
medicine.31,32 Clinical evidence shows that fungal infections
are far more difficult to diagnose, and the importance and se-
verity of fungal infections has only recently started to be rec-
ognized.10 Because of the marked differences in cell walls
between bacteria and fungi, it is not appropriate to expect
that antibacterial surfaces will also be antifungal; while graft
coatings with antiseptics, such as quaternary ammonium
compounds, kill both bacteria and fungi, they also damage
human cell membranes.12
Thus, our conjecture is that to combat fungal infections
and mixed bacterial/fungal infections, it is essential to utilize
a selective antifungal compound, and for mixed infections it
may well be that two-component coatings, one antibacterial
and one antifungal, are required. While some antibacterial
coatings act by disturbing the stability of the bacterial cell
wall, fungi have a different cell wall composition and a
much thicker cell wall, with a thickness of around 100 nm
(Ref. 33) as compared with bacteria where it is only nearly
half as thick.34 When attempting to combat fungal coloniza-
tion of biomedical devices, one must also consider that both
fungal pathogens and mammalian cells are eukaryotic. This
consideration raises concerns whether a prospective coating
will be selective enough to pass cytotoxicity testing.
Accordingly, it would seem preferable to construct antifun-
gal coatings by using compounds, such as caspofungin, that
employ a specific biomolecular pathway unique to fungi
(i.e., glucan pathway), rather than mechanistically acting
nonspecifically through physicochemical disturbance via
electrostatic or surfactant effects. There is, of course, the im-
portant question whether steric hindrance or conformational
changes upon surface immobilization might inhibit the
desired biological activity, but our results show that at least
in some cases a surface-grafted drug may still be able to
interact with a specific biomolecular target, in this case a cell
wall enzyme. Of particular interest may be compounds that
target a biological process that is upregulated upon attach-
ment of microbes to solid surfaces, as in this case where cas-
pofungin inhibits the synthesis of an essential cell wall
component that would be in demand as the cell adapts to the
surface. This increased susceptibility may also enhance se-
lectivity. There would seem to be considerable scope in
defining such approaches based on molecular microbiology
and biomaterials surface science, leading to rationally
designed novel antimicrobial coatings.
V. SUMMARY AND CONCLUSIONS
Caspofungin can be covalently grafted onto biomaterials
surfaces via a propanal plasma polymer interlayer, by reac-
tion between amine groups on caspofungin with surface
aldehyde groups followed by reductive amination. Its pres-
ence has been verified by the surface analytical methods
XPS and ToF-SIMS. While C. albicans attached and grew
on the propanal plasma polymer surface, after immobiliza-
tion of caspofungin, the surface was able to inhibit the for-
mation of Candida biofilm. Some fungal cells managed to
attach but then were killed and thus unable to progress bio-
film formation. In contrast, the presence of caspofungin did
not alter the attachment and spreading of human primary
fibroblast cells, which showed good colonization and normal
morphology both on the plasma polymer surface by itself
and after the grafting of caspofungin. This immobilization
strategy enables the application of antifungal coatings onto a
wide variety of biomaterials and biomedical devices.
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